SVP & Chief Commercial Officer

Chief Commercial Officer & SVP Business development

Corporate VP Global Marketing, Inflammation & Immunology

VP Global Marketing, Inflammation & Immunology

Worldwide Vice-President Immunology

Worldwide VP - CNS

Worldwide Vice-President, Immunology

President, Consumer Medicines

VP Marketing, Consumer Medicines

Product Director, Tylenol

Product Director, Pepcid

SVP & Chief Commercial Officer Areteia Therapeutics

Mark Kreston

AreteiaTx

Chief Information Officer

Chief Digital Officer

Executive Director of Data, Insights and Statistics at NHS Digital

National Provider Support Director

Head of Security and Resilience Programme Management

Southern Programme for IT (SPfIT) Delivery Director

National Programme Office Director

Choose and Book Programme Head

Consultant

Chief Digital Officer at Population Health Partners

Tom Denwood

Chief Development Officer

Partner

Director of the Board and Chair of the Compensation Committee

Chief Development Officer MDCO

Executive Vice President, Chief Development Officer

Senior Vice President Global Innovation Group Leader

Senior Vice President, ACC GIG Health Science Leader

Director of the Board and Chair of the Audit Committee

Vice President, Head of Development

Chairman of the Board and Member of the Audit Committee

Vice President, Innovation Leader, Research & Development

Senior Director Clinical Development & European Medical Affairs

Global Alliance Director

Life Cycle Leader Transplantation

International Medical Manager Transplantation

Country Medical Manager Transplantation

Postdocteral Fellow

Postdoctoral Fellow

Laboratory Technician

Partner at Population Health Partners

Peter Wijngaard

Chief Executive Officer

President Janssen Canada

Vice President Cardiovascular Sales and Marketing

Senior Vice President, Business Unit Leader

Vice President Medical Center Business Unit

Area Vice President Senior Care Business

Management Associate

Chief Executive Officer, Areteia Therapeutics

Jorge Bartolome

Chief Financial Officer

CFO, VP of Finance

Christopher Courts

Senior Vice President, Chief Scientific Officer

Special Volunteer, Allergy & Immunology Training Program

Vice President, Clinical and Translational Medicine

Senior Director, Clinical and Translational Medicine

Chair (2015), Member (2012-2017) ABAI Board of Directors

Head, Lymphocyte Biology Unit, NIAID

Member, FDA Pulmonary-Allergy Drugs Advisory Committee

Associate Director, A&I Clinical Training Program

Staff Physician, Clinical Investigator, Laboratory of Allergic Disease

Commissioned Officer, retired @ O-6 grade

Calman Prussin

Head of Policy and Partnerships

Director

Tamsin Berry

V.P. Global Head of Quality

Principal

Vice President Quality Assurance

Senior Director Operations

Lex Kay

Head of Human Strategy

SVP Human Strategy & Operating Partner

Chief Human Strategy Officer

Advisor

Chief Human Resources Officer

Sr. Vice President Human Strategy

Vice President Global Human Resources

Vice President Human Resources

Sr. Director Human Strategy

Sr. Director Human Resources

Director Human Resources

Entrepreneural Human Strategist

Richard Fires

Senior Director, Clinical Operations

Director, Clinical Operations

Associate Director Site Management

Associate Director Clinical Operations

Manager, Clinical Operation

Senior Clinical Research Associate

Clinical Research Associate II

Clinical Research Coordinator II

Laboratory Technician/Blood Bank

Optician/Ophthalmic Technician

Laboratory Researcher/ Data Manager

Lab Assistant

Optician

Senior Director of  Clinical Operations at Areteia Therapeutics

Boontaricka Boonyapredee

Sr. Director Global Clinical Supply Chain

Associate Director, Drug Supply

Director Supply Chain

Sr. Manager, Supply Chain

Associate Director, Materials Management

Planner, Manufacturing Operations

Sr. Analyst, Distribution & Logistics

Associate Manager, Supply Chain

Senior Financial Analyst

Kevin Cpim

Senior Director of Finance

Senior Accountant

Accounting Manager

Director of Finance

Controller/Director of Finance

Financial Analyst

Controller

Ericka Goss

Sr. Director QA GMP Compliance

Director of Quality Late Phase/Commercial

Quality and Compliance Principal Consultant

Sr. Director Supplier Quality Management & GMP Auditing

Director, Supplier Quality Management & GMP Auditing

Associate Director, Quality Assessments

Sr. Manager Third Party QA

Manager Quality

QC Chemist

Herbert Vail

Advisory Board Member

Associate Director, Clinical Operations Lead

Senior Clinical Study Manager

Senior Project Manager

Clinical Trial Manager

Clinical Project Manager

Clinical Research Associate

Assistant Clinical Research Associate

Senior Clinical Operations Coordinator

Senior Clinical Research Coordinator

Research Coordinator

Psychometrist

Associate Director, Clinical Operations

Cheryl Knipe

Areteia Therapeutics is a biotechnology company focused on developing innovative treatments for cognitive impairment associated with neuropsychiatric conditions.

Areteia Therapeutics

Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eosinophilic asthma.

Maverick Capital

Population Health Partners

Access Biotechnology

ARCH Venture Partners

Google Ventures

Sanofi

Saturn Partners

Bain Capital Life Sciences

“I am excited that Dan has been appointed to our board,” said Jorge Bartolome, President and Chief Executive Officer of Areteia. “He is an incredibly accomplished executive whose depth of biotech experience, proven leadership and scientific expertise will be invaluable to me and the Board of Directors as we focus on delivering on the Company’s strategy and further advancing the Phase III program for dexpramipexole, the first potential oral drug for eosinophilic asthma.”

Areteia Therapeutics Announces Additional $75MM in Series A Financing for Oral Dexpramipexole in Eosinophilic Asthma - We are proud to announce that this will support significant expansion of the existing program, including adding clinical development in Japan along with several additional global markets, expansion of manufacturing activities and additional life-cycle management including development of a once-daily formulation.
Viking Global Investors and Marshall Wace to join the syndicate. More information here: https://lnkd.in/eUBs-de8

We are pleased to announce that results from the phase II EXHALE-1 study of oral dexpramipexole in eosinophilic asthma have been published online in the Journal of Allergy and Clinical Immunology. 

Jefferies Healthcare Conference (@Marriott Marquis in NYC) 

7-9th June 2023

Please come and meet Jorge Bartolome our CEO, Chris Courts our CFO, and Eric Bradford our CMO. We are presenting Wednesday, June 7th at 4:00-4:25 PM in Track 9.

We look forward to seeing you, and discussing all things eosinophilic asthma.

https://lnkd.in/gFfcbnWw

#healthcare #asthma #eosinophils


Photo	Title	Links
	Mark Kreston SVP & Chief Commercial Officer
	Tom Denwood Chief Information Officer
	Peter Wijngaard Chief Development Officer
	Jorge Bartolome Chief Executive Officer
	Christopher Courts Chief Financial Officer
	Calman Prussin Senior Vice President, Chief Scientific Officer
	Tamsin Berry Head of Policy and Partnerships
	Lex Kay V.P. Global Head of Quality
	Richard Fires Head of Human Strategy
	Boontaricka Boonyapredee Senior Director, Clinical Operations
	Kevin Cpim Sr. Director Global Clinical Supply Chain
	Ericka Goss Senior Director of Finance
	Herbert Vail Sr. Director QA GMP Compliance
	Cheryl Knipe Associate Director Clinical Operations

COM:ARETEIATX